Advanced search    

Search: Oncology

136,493 papers found. Showing first 1,000 results.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Exploring the needs and resources of children in a haematology-oncology unit

Too often a child's body is restored to health in the hospital, but the child is sent home with emotional wounds. This study explored the needs of children in a haematology-oncology unit as well as ... field study was then conducted in order to prioritise the resources according to their importance for children in a haematology-oncology unit. A definite trend could be found in the way that the children

Safety of Novel Targeted Therapies in Oncology

targeted therapies in oncology across a range of pharmacotherapeutic classes. Procaccio and colleagues [7] reviewed approved as well as investigational antiangiogenic and vascular disrupting agents in the ... profiling: a single center study. Cancer Res. 2016;76:3690–701.CrossRefGoogle Scholar 5. Sánchez NS, Mills GB, Mills Shaw KR. Precision oncology: neither a silver bullet nor a dream. Pharmacogenomics

What is happening with the supply of oncology drugs in Brazil and the world?

Campinas - UNICAMP, Campinas, SP, Brazil Corresponding author     The continuity of the supply of drugs used in oncology and oncohematology, which are on the whole irreplaceable, has been the cause ... related to the quality of available products as the vast majority of the 'old' drugs used in oncology are products considered 'similar medications', whose origin, bioequivalence, production process and

Learning from data to predict future symptoms of oncology patients

Effective symptom management is a critical component of cancer treatment. Computational tools that predict the course and severity of these symptoms have the potential to assist oncology clinicians ... evidence, [ 1?3 ] as well as clinical experience suggests that the symptom experience of oncology patients is extremely variable. While some patients experience very few symptoms, other patients undergoing

Prognostic and Predictive Epigenetic Biomarkers in Oncology

There is a broad spectrum of epigenetic biomarkers in oncology, but those related to methylation and microRNA (miRNA) copy number variation or changed expression seem to be the most promising. There ... , it seems that miRNAs and circulating tumor DNA are the most promising biological material to work with in personalized oncology. 1 Introduction Genetic information is provided by the order of

Oncolytic virus immunotherapy: future prospects for oncology

biologyCancer Immunoediting Background Scope of Immuno-oncology Medical oncology is in the midst of a massive paradigm shift: previously markedly toxic and poorly selective systemic chemotherapy and ... -years for advanced cancers. Notably, such treatments are able to induce up to total regression or remission [5, 6]. Intriguingly though the principle of immuno-oncology has long existed. Historically

Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One

Precision medicine is a term describing strategies to promote health and prevent and treat disease based on an individual’s genetic, molecular, and lifestyle characteristics. Oncology precision ... Scott M. Weissman Brenda Ramczyk Pharmacology Commons Neoplasms Commons Oncology Commons Public Health Commons 0 Aurora Research Institute, Aurora Health Care , Milwaukee, WI , USA 1 Aurora Cancer Care

Carbon fibre/polyether ether ketone (CF/PEEK) implants in orthopaedic oncology

in musculoskeletal oncology, especially when encountering multiple or osteolytic lesions. Often, a surgical stabilization with implants is required. However, metallic implants not only impair the CT ... musculoskeletal surgery. It already has been investigated in spinal surgery [2, 3, 12, 13], but the literature still lacks clinical evidence in musculoskeletal oncology [4]. To our best knowledge, we hereby report

Knowledge base toward understanding actionable alterations and realizing precision oncology

oncology  Introduction Cancer is a disease caused by genetic mutation, with common mutations that occur across cancer types yet vary among individual patients. Traditional cancer treatment involves the ... curation process that is essential in the practice of precision oncology. Comprehensive cancer panel sequencing tests Gene panel testing is a technique that simultaneously analyzes multiple genes using

Associations between clinical and sociodemographic data and patterns of communication in pediatric oncology

. Zwaanswijk M, Tates K, van Dulmen S, Hoogerbrugge PM, Kamps WA, Beishuizen A, et al. Communicating with child patients in pediatric oncology consultations: A vignette study on child patients’, parents’, and ... survivors’ communication preferences. Psycho-Oncology. 2011;20:269–77. http://​dx.​doi.​org/​10.​1002/​pon.​1721. [ Links ] Received: March 10, 2016; Revised: April 7, 2016; Accepted: April 18, 2016

Pediatric Oncology

Complementary Journal of Oncology Disease nal and Mathematical Methods Hindawi Publishing Corporation ht p:/ AIDS and ology

Division of Gynecologic Oncology

The Gynecologic Oncology Division at the University of Iowa consists of four attending physicians, three fellows-in-training, two physician assistants, three nurses and supporting research and ... research through participation in clinical trials as well as a laboratory research initiative by Dr. Michael Goodheart. The division has been a member of the Gynecologic Oncology Group since shortly after

Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement

To develop recommendations for clinical trial reporting that address the unique efficacy, toxicity, and combination and sequencing aspects of immuno-oncology (IO) treatments. ASCO and the Society for ... representatives from industry and government to develop Trial Reporting in Immuno-Oncology (TRIO) recommendations. These recommendations are based on expert consensus, given that existing data to support evidence

Radiation Oncology

, Charles Nicholas Catton1 1Radiation Medicine Program, Princess Margaret Hospital and The University Of Toronto, 2Department of Surgical Oncology, Princess Margaret Hospital and The University of Toronto

Medical Oncology

James C Wittig 5 6 Dhruv Kumar 5 6 Dennis Priebat 5 6 Robert M Henshaw 5 6 Martin M Malawer 5 6 0 Oncology Service Dept. of Orthopedics Karolinska Hospital 1 Dept. of Orthopedics Haukeland University ... Hospital 2 Dept. of Oncology Lund University Hospital 3 Dept of Orthopedics Lund University Hospital 4 Dept of Orthopedics Soder Hospital 5 010 The SSG Register - Tool for Clinical Research H C Bauer 6

The Past of Cellular Oncology

Cellular Oncology The past of Cellular Oncology Albrecht Reith - I was pleased, when the new editor of Cellular Oncology, Gerrit Meijer, asked me to look back at my five years as editor-in-chief ... of Analytical Cellular Pathology and to write an editorial of my experience of this time. A farewell-for Analytical Cellular Pathology by me [ 1 ] and a hello-to Cellular Oncology by the president of

Correction to: Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship

the original article, L. Mark Knab’s first name was tagged incorrectly. Copyright information © Society of Surgical Oncology 2018 Authors and Affiliations L. Mark Knab1Mazen S. Zenati1Anton

Pharmacovigilance in oncology

the safety of drugs, is particularly important in oncology, due to the intrinsic biologic toxicity of antineoplastic agents, their narrow therapeutic windows, and the high doses and rigid timing of ... issues in carrying out an effective pharmacovigilance activity in oncology. Method We searched PubMed for articles about pharmacovigilance in relation to chemotherapy, radiotherapy and targeted therapy for

A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)

Department of radiation oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 3 The Proton Therapy Center, Research Institute and Hospital, National Cancer

Adoptive cell transfer: new perspective treatment in veterinary oncology

outcomes for canine patients. It is warranted to determine whether veterinary clinical trials could support comparative oncology research and thus facilitate the development of new cell-based therapies for ... -based therapies for humans. Herein, we discuss adoptive transfer of T lymphocytes and lymphokine-activated cells for application in veterinary oncology, in the context of human medicine achievements